首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性髓细胞性白病融合基因异构体分型与bcl—2表达,临床预 …
引用本文:柳金,刘振华.急性髓细胞性白病融合基因异构体分型与bcl—2表达,临床预 …[J].湖南医科大学学报,2000,25(6):564-566.
作者姓名:柳金  刘振华
作者单位:湖南医科大学附属湘雅医院血液科,长沙
摘    要:采用免疫组化、原位杂交方法,测定28例急性早幼粒白血病(APL)患者的抗凋亡基因bcl-2蛋白/mRNA表达水平,并分析APL融合基因异构体分型与bcl-2基因表达、临床预后的关系。结果表明,异构体之间的bcl-2蛋白/mRNA表达水平差异无显著性(P〉0.05)。提示PML-RAPα转录构型不影响临床特征和预后。

关 键 词:bcl-2基因  预后  急性髓细胞性白血病  融合基因

The relationship between clinical prognosis and classification of the isoforms of fuse gene in acute promyelocytic leukemia]
J Liu,Z H Qi,P Cao.The relationship between clinical prognosis and classification of the isoforms of fuse gene in acute promyelocytic leukemia][J].Bulletin of Hunan Medical University,2000,25(6):564-566.
Authors:J Liu  Z H Qi  P Cao
Institution:Department of Hematology, Xiangya Hospital, Hunan Medical University, Changsha 410008.
Abstract:To check the anti-apoptosis gene bcl-2 protein/mRNA expression in 28 acute promyelocytic leukemia (APL), by immunohistochemistry and in situ hybridization, and to analyse the relationship among the bcl-2 gene expressions, clinical prognosis and classification of the isoforms of fuse gene in APL. The result shows the two types of isoforms of PML-RAR alpha have no significance in bcl-2 protein/mRNA expression, indexes of clinical prognosis. This shows that the classification of PML-RAR alpha isoform has no influence on clinical prognosis.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号